Dr. Parameswaran Hari is a hemato-oncologist specializing in cell therapy, transplantation, and clinical gene therapy. He is currently the Chief Development Officer of Obsidian Therapeutics a biotech engaged in Precision Cell and Gene Therapy. He had a long academic career prior to joining the biotech industry and served roles as Chief of Hematology Oncology at the Medical College of Wisconsin, Scientific Director for the Center for International Blood and Marrow Transplant Research (CIBMTR) and Secretary of the American Society for Transplantation and Cellular Therapy (ASTCT). His clinical interests are in plasma cell disorders and cellular therapeutics.